{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:20:55Z","timestamp":1783459255959,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.diabres.2026.113354","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:14:40Z","timestamp":1780503280000},"page":"113354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic crosstalk in breast cancer in patients with Type 2 diabetes mellitus: pathophysiology and nanotherapeutic opportunities for clinical translation"],"prefix":"10.1016","volume":"238","author":[{"given":"Anastacia","family":"Wakens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danzil","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-5368","authenticated-orcid":false,"given":"Sanjeev","family":"Rambharose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113354_b0005","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2021"},{"key":"10.1016\/j.diabres.2026.113354_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.800714","article-title":"Antidiabetic Phytochemicals from Medicinal Plants: prospective Candidates for New Drug Discovery and Development","volume":"13","author":"Alam","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2026.113354_b0015","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cancers17071102","article-title":"Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies","author":"Carvalho","year":"2025","journal-title":"Cancers [Internet]"},{"key":"10.1016\/j.diabres.2026.113354_b0020","doi-asserted-by":"crossref","unstructured":"J.S. Lee C.E. Tocheny L.M. Shaw The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target 12(12).doi: 2022 Life (Basel) 10.3390\/life12121992.","DOI":"10.3390\/life12121992"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","article-title":"Metabolic reprogramming in triple-negative breast cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"6","key":"10.1016\/j.diabres.2026.113354_b0030","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2337\/diacare.26.6.1752","article-title":"Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study","volume":"26","author":"Michels","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-023-07043-6","article-title":"Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"202","author":"Jordt","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.diabres.2026.113354_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.puhe.2025.105914","article-title":"Diabetes driven effects on incidence and mortality of breast cancer: a meta-analysis","volume":"247","author":"Rashmi","year":"2025","journal-title":"Public Health"},{"issue":"8","key":"10.1016\/j.diabres.2026.113354_b0045","first-page":"807","article-title":"Cancer incidence in the National Health and Nutrition Survey I. follow-up data: diabetes, cholesterol, pulse and physical activity","volume":"4","author":"Steenland","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.diabres.2026.113354_b0050","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/carcin\/bgm081","article-title":"Diabetes and risk of breast cancer in Asian-American women","volume":"28","author":"Wu","year":"2007","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.diabres.2026.113354_b0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10549-015-3323-5","article-title":"The association between diabetes and breast cancer stage at diagnosis: a population-based study","volume":"150","author":"Lipscombe","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.diabres.2026.113354_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111665","article-title":"Associations between diabetes and cancer: a 10-year national population-based retrospective cohort study","volume":"211","author":"Safadi","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2026.113354_b0065","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/JOE-18-0037","article-title":"Metabolic reprogramming in type 2 diabetes and the development of breast cancer","volume":"237","author":"Martin","year":"2018","journal-title":"J Endocrinol"},{"key":"10.1016\/j.diabres.2026.113354_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.728759","article-title":"Glucose Metabolism and Glucose Transporters in Breast Cancer","volume":"9","author":"Shin","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"18","key":"10.1016\/j.diabres.2026.113354_b0075","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1002\/1873-3468.12360","article-title":"Measuring relative utilization of aerobic glycolysis in breast cancer cells by positional isotopic discrimination","volume":"590","author":"Yang","year":"2016","journal-title":"FEBS Lett"},{"issue":"3215","key":"10.1016\/j.diabres.2026.113354_b0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.diabres.2026.113354_b0085","article-title":"Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.diabres.2026.113354_b0090","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/01635581.2019.1654527","article-title":"Higher Glucose Enhances Breast Cancer Cell Aggressiveness","volume":"72","author":"Santos","year":"2020","journal-title":"Nutr Cancer"},{"issue":"5","key":"10.1016\/j.diabres.2026.113354_b0095","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41392-020-00326-0","article-title":"NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications","volume":"5","author":"Ju","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.diabres.2026.113354_b0105","article-title":"The complexity of the serine glycine one-carbon pathway in cancer","volume":"219(1).doi","author":"Reina-Campos","year":"2020","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2017.89","article-title":"Biochemical and cellular properties of insulin receptor signalling","volume":"19","author":"Haeusler","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.diabres.2026.113354_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101304","article-title":"Insulin action at a molecular level \u2013 100 years of progress","volume":"52","author":"White","year":"2021","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.diabres.2026.113354_b0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-020-0329-9","article-title":"Insulin\u2013PI3K signalling: an evolutionarily insulated metabolic driver of cancer","volume":"16","author":"Hopkins","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0125","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.diabres.2026.113354_b0130","series-title":"Type 2 Diabetes [Working Title]","article-title":"Oxidative stress, DNA damage and Repair Pathways in patients with Type 2 Diabetes Mellitus","author":"E.B.F. Lima J, J. Xavier D, T. Sakamoto-Hojo E.","year":"2019"},{"issue":"4","key":"10.1016\/j.diabres.2026.113354_b0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12282-024-01567-5","article-title":"PI3K\/AKT\/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Breast Cancer"},{"key":"10.1016\/j.diabres.2026.113354_b0140","article-title":"PI3K\/Akt\/mTOR Pathway and its Role in Cancer Therapeutics: are we making Headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.diabres.2026.113354_b0145","article-title":"PTEN Alterations and their Role in Cancer Management: are we making Headway on Precision Medicine?","volume":"11(7).doi","author":"Fusco","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.diabres.2026.113354_b0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.diabres.2026.113354_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1611842","article-title":"Linking oxidative stress biomarkers to disease progression and antioxidant therapy in hypertension and diabetes mellitus","volume":"12","author":"Nunez-Selles","year":"2025","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12964-023-01398-5","article-title":"Interplay of oxidative stress, cellular communication and signaling pathways in cancer","volume":"22","author":"Iqbal","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.diabres.2026.113354_b0165","article-title":"Oxidative stress in Cancer Cell Metabolism","volume":"10(5).doi","author":"Arfin","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.diabres.2026.113354_b0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coph.2021.11.010","article-title":"The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: a target for new therapies against cardiovascular diseases","volume":"62","author":"Andreadi","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.diabres.2026.113354_b0175","article-title":"Hyperglycemia and Oxidative stress: an Integral, Updated and critical Overview of their Metabolic Interconnections","volume":"24(11).doi","author":"Gonzalez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113354_b0180","article-title":"Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency","volume":"8(23).doi","author":"Panigrahi","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.diabres.2026.113354_b0185","doi-asserted-by":"crossref","unstructured":"R. Dong J. Wang R. Guan J. Sun P. Jin J. Shen Role of Oxidative Stress in the Occurrence, Development and Treatment of Breast Cancer 14(1).doi 2025 Antioxidants (Basel) 10.3390\/antiox14010104.","DOI":"10.3390\/antiox14010104"},{"key":"10.1016\/j.diabres.2026.113354_b0190","article-title":"The Role of Chronic Inflammation in the Development of Breast Cancer","volume":"13(15).doi","author":"Danforth","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.diabres.2026.113354_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9965916","article-title":"The Involvement of the Oxidative stress Status in Cancer Pathology: a double View on the Role of the Antioxidants","volume":"2021","author":"Zahra","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.diabres.2026.113354_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104741","article-title":"Mechanistic insights of adipocyte metabolism in regulating breast cancer progression","volume":"155","author":"Zhang","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.diabres.2026.113354_b0205","article-title":"Mitochondrial Redox Vulnerabilities in Triple-negative Breast Cancer: Integrative Perspectives and Emerging Therapeutic strategies","volume":"16(1).doi","author":"Cruz-Gregorio","year":"2026","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s40364-024-00653-2","article-title":"DNA damage response in breast cancer and its significant role in guiding novel precise therapies","volume":"12","author":"Li","year":"2024","journal-title":"Biomark Res"},{"key":"10.1016\/j.diabres.2026.113354_b0215","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.3390\/cimb46050282","article-title":"Oxidative stress in Breast Cancer: a Biochemical Map of Reactive Oxygen Species Production","author":"Bel\u2019skaya LV, Dyachenko EI.","year":"2024","journal-title":"Current Issues in Molecular Biology [Internet]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0220","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1038\/sigtrans.2017.36","article-title":"Redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategy","volume":"2","author":"Jiang","year":"2017","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.diabres.2026.113354_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028454","article-title":"Direct sensing of endothelial oxidants by vascular endothelial growth factor receptor-2 and c-Src","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/CM9.0000000000003230","article-title":"Oxidative stress in diabetes mellitus and its complications: from pathophysiology to therapeutic strategies","volume":"138","author":"Chen","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.diabres.2026.113354_b0235","article-title":"Influence and treatment of insulin receptor substrate\/PI3K\/Akt\u2011mediated insulin resistance in diabetes mellitus (Review)","volume":"33(2).doi","author":"Tang","year":"2026","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.diabres.2026.113354_b0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer Treatment: a Review","volume":"321","author":"Waks","year":"2019","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113354_b0245","article-title":"Diabetes Comorbidity and Quality of Life in patients with Cancer: a prospective Study in an Integrative Oncology setting","volume":"14(6).doi","author":"Kassem","year":"2025","journal-title":"J Clin Med"},{"issue":"13","key":"10.1016\/j.diabres.2026.113354_b0250","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1200\/JCO.2008.17.5935","article-title":"Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer","volume":"27","author":"Srokowski","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113354_b0255","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/dc17-2012","article-title":"The Impact of Diabetes on Breast Cancer Treatments and Outcomes: a Population-based Study","volume":"41","author":"Lega","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2026.113354_b0260","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jnci\/djae261","article-title":"Risk of type 2 diabetes after breast cancer treatment: a population-based cohort study in Denmark","volume":"117","author":"Kjaergaard","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41574-023-00899-0","article-title":"Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy","volume":"20","author":"Thomas","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabres.2026.113354_b0270","article-title":"Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer","volume":"13(1).doi","author":"Shum","year":"2023","journal-title":"J Pers Med"},{"issue":"9","key":"10.1016\/j.diabres.2026.113354_b0275","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"7503","key":"10.1016\/j.diabres.2026.113354_b0280","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0285","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1038\/s41598-025-87537-z","article-title":"Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling","volume":"15","author":"Xia","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2026.113354_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1631415","article-title":"Metformin enhances alpelisib sensitivity in HER2+ breast cancer by suppressing cancer stemness and oncogenic signaling","volume":"15","author":"Shi","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.diabres.2026.113354_b0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2020.09.012","article-title":"Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect","volume":"495","author":"Shi","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.diabres.2026.113354_b0300","article-title":"Additive Anticancer and Antioxidant Effects of Metformin and Luteolin in Breast and Colorectal Cancer Cell Lines","volume":"18(11).doi","author":"Gebczak","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.diabres.2026.113354_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.crfs.2024.100715","article-title":"Bioavailability and mechanisms of dietary polyphenols affected by non-thermal processing technology in fruits and vegetables","volume":"8","author":"Liu","year":"2024","journal-title":"Curr Res Food Sci"},{"key":"10.1016\/j.diabres.2026.113354_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1155622","article-title":"A review on nanoparticles: characteristics, synthesis, applications, and challenges","volume":"14","author":"Altammar","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.diabres.2026.113354_b0315","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.3390\/molecules29153482","article-title":"A Comprehensive Review of Nanoparticles: from Classification to Application and Toxicity","author":"Eker","year":"2024","journal-title":"Molecules [Internet]"},{"issue":"10","key":"10.1016\/j.diabres.2026.113354_b0320","first-page":"1035","article-title":"Effects of insulin-loaded chitosan-alginate nanoparticles on RAGE expression and oxidative stress status in the kidney tissue of rats with type 1 diabetes","volume":"21","author":"Heidarisasan","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.diabres.2026.113354_b0325","doi-asserted-by":"crossref","first-page":"10749","DOI":"10.3389\/ebm.2025.10749","article-title":"Protective effects of berberine-loaded chitosan\/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats","volume":"250","author":"Liu","year":"2025","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0330","doi-asserted-by":"crossref","first-page":"20677","DOI":"10.1038\/s41598-021-00108-w","article-title":"Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes","volume":"11","author":"Abdulmalek","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.diabres.2026.113354_b0335","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/tox.23903","article-title":"Luteolin\/ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA-124 by targeting C\/EBPA","volume":"38","author":"Moustafa","year":"2023","journal-title":"Environ Toxicol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113354_b0340","first-page":"54","article-title":"Biosynthesis of gold nanoparticles and their protective effect towards diabetic nephropathy by inhibition of oxidative stress","volume":"36","author":"Qu","year":"2025","journal-title":"Biomed Mater Eng"},{"issue":"12","key":"10.1016\/j.diabres.2026.113354_b0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0335165","article-title":"Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K\/AKT\/mTOR pathway downregulation","volume":"20","author":"Givi","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2026.113354_b0350","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/7145339","article-title":"Anticancer Action of Silver Nanoparticles in SKBR3 Breast Cancer Cells through Promotion of Oxidative stress and Apoptosis","volume":"2024","author":"Vahabirad","year":"2024","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.diabres.2026.113354_b0355","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.2147\/IJN.S228652","article-title":"Investigation of the Role of Glucose decorated Chitosan and PLGA Nanoparticles as Blocking Agents to Glucose Transporters of Tumor Cells","volume":"14","author":"Abolhasani","year":"2019","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.diabres.2026.113354_b0360","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.colsurfb.2017.05.032","article-title":"Folate\/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: a comparative study","volume":"156","author":"Kumar","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"4","key":"10.1016\/j.diabres.2026.113354_b0365","doi-asserted-by":"crossref","first-page":"9754","DOI":"10.1080\/21655979.2022.2060721","article-title":"Tumor targetable and pH-sensitive polymer nanoparticles for simultaneously improve the Type 2 Diabetes Mellitus and malignant breast cancer","volume":"13","author":"Tang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.diabres.2026.113354_b0370","article-title":"Nanoencapsulation of nutraceuticals: enhancing stability and bioavailability in functional foods","volume":"12","author":"Hao","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.diabres.2026.113354_b0375","article-title":"Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs","volume":"11(8).doi","author":"Twarda-Clapa","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.diabres.2026.113354_b0380","article-title":"Exploring Oxidative stress Mechanisms of Nanoparticles using Zebrafish (Danio rerio)","volume":"14(4).doi","author":"Batir-Marin","year":"2025","journal-title":"Toxicological and Pharmaceutical Insights Antioxidants (Basel)"},{"key":"10.1016\/j.diabres.2026.113354_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.943906","article-title":"Nanomedicines Targeting Metabolism in the Tumor Microenvironment","volume":"10","author":"Ren","year":"2022","journal-title":"Front Bioeng Biotechnol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:04:10Z","timestamp":1783458250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726002743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":77,"alternative-id":["S0168822726002743"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113354","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic crosstalk in breast cancer in patients with Type 2 diabetes mellitus: pathophysiology and nanotherapeutic opportunities for clinical translation","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113354"}}